Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285580 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2023. Verfasst von Alexander Runkel und 19 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Plastic and Hand Surgery, Medical Center-University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Multiparametric Magnetic Resonance Imaging, Circulating Tumor DNA, Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Forschungskommission Freiburg, Faculty of Medicine, University of Freiburg, Faculty of Medicine, University of Freiburg.
Abstract (Originalsprache)
Background
Wide resection remains the cornerstone of localized soft-tissue sarcomas (STS) treatment. Neoadjuvant radiation therapy (NRT) may decrease the risk of local recurrences; however, its effectiveness for different histological STS subtypes has not been systematically investigated. The proposed prospective study evaluates the NRT response in STS using liquid biopsies and the correlation of multiparametric magnetic resonance imaging (mpMRI) with histopathology and immunohistochemistry.
Methods
Patients with localized high-grade STS, who qualify for NRT, are included in this study. Liquid biopsies Quantification of circulating tumor DNA (ctDNA) in patient blood samples is performed by targeted next-generation sequencing. Soft-tissue sarcoma subtype-specific panel sequencing in combination with patient-specific exome sequencing allows the detection of individual structural variants and point mutations. Circulating free DNA is isolated from peritherapeutically collected patient plasma samples and ctDNA quantified therein. Identification of breakpoints is carried out using FACTERA. Bioinformatic analysis is performed using samtools, picard, fgbio, and the MIRACUM Pipeline. mpMRI Combination of conventional MRI sequences with diffusion-weighted imaging, intravoxel-incoherent motion, and dynamic contrast enhancement. Multiparametric MRI is performed before, during, and after NRT. We aim to correlate mpMRI data with the resected specimen’s macroscopical, histological, and immunohistochemical findings.
Results
Preliminary data support the notion that quantification of ctDNA in combination with tumor mass characterization through co-registration of mpMRI and histopathology can predict NRT response of STS. Clinical relevance The methods presented in this prospective study are necessary to assess therapy response in heterogeneous tumors and lay the foundation of future patient- and tumor-specific therapy concepts. These methods can be applied to various tumor entities. Thus, the participation and support of a wider group of oncologic surgeons are needed to validate these findings on a larger patient cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Plastic and Hand Surgery, Medical Center-University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, Berta-Ottenstein-Programme, University of Freiburg, Freiburg, Germany.
- Division of Hand, Plastic and Aesthetic Surgery, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.
- Faculty of Medicine, Department of Radiology, Medical Center-University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, Department of Medicine I, Medical Center-University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, Institute of Medical Bioinformatics, Medical Center-University of Freiburg, Freiburg, Germany.
ORCID-Profile: Alexander Runkel, David Braig
Förderung
- Forschungskommission Freiburg, Faculty of Medicine, University of Freiburg
- Faculty of Medicine, University of Freiburg
Zitieren
APA
Runkel, A., Braig, D., Bogner, B., Schmid, A., Lausch, U., Boneberg, A., Brugger, Z., Eisenhardt, A., Kiefer, J., Pauli, T., Boerries, M., Fuellgraf, H., Kurowski, K., Bronsert, P., Scholber, J., Grosu, A. L., Rovedo, P., Bamberg, F., Eisenhardt, S. U., & Jung, M. (2023). Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0285580
Vancouver
Runkel A, Braig D, Bogner B, Schmid A, Lausch U, Boneberg A, et al. Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol. PLOS ONE. 2023. doi:10.1371/journal.pone.0285580
BibTeX
@article{Runkel2023,
author = {Runkel, Alexander and Braig, David and Bogner, Balazs and Schmid, Adrian and Lausch, Ute and Boneberg, Anika and Brugger, Zacharias and Eisenhardt, Anja and Kiefer, Jurij and Pauli, Thomas and Boerries, Melanie and Fuellgraf, Hannah and Kurowski, Konrad and Bronsert, Peter and Scholber, Jutta and Grosu, Anca-Ligia and Rovedo, Philipp and Bamberg, Fabian and Eisenhardt, Steffen Ulrich and Jung, Matthias},
title = {Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285580}
}
EUVIMED